-
FDA Action Alert: GSK, Alnylam, Sanofi and More
10 Mar 2025 21:08 GMT
… this month is for Alnylam Pharmaceuticals, which is seeking … and its cardiomyopathy manifestations.
Alnylam’s bid for label … of ATTR, according to Alnylam.
Theratechnologies Tries Again for … on GSK’s investigational antibiotic gepotidacin for the treatment …
-
The findings from Alnylam’s highly anticipated readout
24 Jun 2024 15:32 GMT
… On top of today’s Alnylam news, we have Congress … phage therapy.
Alnylam’s highly anticipated readout
Alnylam this morning … interest in research dwindled after antibiotics took off.
Smith points … many advantages phages have over antibiotics — such as low …
-
Alnylam’s amyloidosis drug heads latest crop of CHMP approvals
30 Jul 2018 11:27 GMT
… ahead of the weekend, including Alnylam’s patisiran for hereditary transthyretin … the first product approval for Alnylam, an RNA interference specialist which … Xerava (eravacycline), a new fluorocycline antibiotic for complicated intra-abdominal infections …
-
AGN's Superbug Antibiotic Gets FDA Nod, AFMD Soars, Boxed Warning For Ocaliva
02 Feb 2018 03:15 GMT
… and CD30-Positive Lymphomas; Alnylam's upcoming regulatory … s expanded label for superbug antibiotic AVYCAZ; Boxed Warning for … .85, up 39.62%.
Alnylam Pharmaceuticals Inc.'s (ALNY … #39;s (AGN) superbug antibiotic AVYCAZ for yet another indication …
-
Global Biodefense Market 2020 Emerging Trends, Share, Opportunities, COVID-19 Impact Analysis and Forecast-2026
30 Jun 2020 05:18 GMT
… by Product (Vaccines, Detection Devices, Antibiotics, Masks)” New Document to its …
Achaogen, Inc.
Alexeter Technologies LLC
Alnylam Pharmaceuticals, Inc.
Altimmune, Inc.
Bavarian …
-
Atypical Hemolytic Uremic Syndrome Treatment Market Report For M&A, Expansion, And Competitive Benchmarking (2025–2034)
16 Jun 2025 13:11 GMT
… Ltd., Chugai Pharmaceutical Co. Ltd., Alnylam Pharmaceuticals Inc., Vifor Pharma Ltd … , Plasma Exchange Therapy, Supportive Care, Antibiotics
2 By Route of Administration …
-
Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
07 May 2025 20:01 GMT
… serves on the boards of Alnylam Pharmaceuticals, Inc., AvenCell Therapeutics, Inc … with high case-fatality rates, antibiotic resistance and meningitis, while maintaining …
-
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
01 May 2025 12:00 GMT
… driven by the overuse of antibiotics.” About Dr. Brandicourt
Dr. Brandicourt … serves on the boards of Alnylam Pharmaceuticals, Inc., AvenCell Therapeutics, Inc … with high case-fatality rates, antibiotic resistance and meningitis, while maintaining …
-
FDA News Month in Review: March 2025
31 Mar 2025 20:32 GMT
… -CM
On March 20, 2025, Alnylam announced FDA approval of vutrisiran … . Gepotidacin, a first-in-class antibiotic, works by inhibiting bacterial DNA …
-
Rx Rundown: Merck, Novo Nordisk, GSK and more
28 Mar 2025 12:35 GMT
… rights to market two generic antibiotics.
Ionis Pharmaceuticals expanded its partnership … the FDA.
The FDA approved Alnylam Pharmaceuticals’ Amvuttra for a rare …
About
© 1995-2025